Stockscreener 앱 받기
120.51
8.52%
-11.23
시간 외 거래:
120.90
0.39
+0.32%
Abbott Laboratories 주식(ABT)의 최신 뉴스
Abbott Laboratories: Temporary Challenges Amid Strong Long-Term Growth Prospects Justify Buy Rating - TipRanks
Abbott med tech bumps up Q2 results - BioWorld MedTech
Abbott Laboratories: Strong Medical Devices Performance and Resilient Growth Amid Challenges - TipRanks
Abbott Labs stock price target lowered to $145 at BTIG on China headwinds By Investing.com - Investing.com South Africa
Abbott Laboratories stock underperforms Thursday when compared to competitors - MSN
These Stocks Moved the Most Today: Lucid, TSMC, Elevance, Sarepta, PepsiCo, Abbott Labs, Archer Daniels, and More - Barron's
Nasdaq rises, Dow Jones inches ahead as Abbott outlook disappoints, Pepsi impresses - Proactive financial news
Abbott flags over $1 billion hit in 2025 from tariffs, COVID test decline - MSN
Abbott posts Q2 beat, lowers high end of guidance - MassDevice
Why Abbott Laboratories (ABT) Shares Are Plunging Today - Yahoo Finance
Abbott Reports 10.5% EPS Growth for Fiscal Q2 - The Globe and Mail
Biochip Market Global Outlook Report 2025, with Focus on Microarrays and Lab-on-a-Chip - GlobeNewswire Inc.
Abbott Labs stock price target lowered to $140 by Evercore ISI - Investing.com
Abbott Labs stock falls as Goldman Sachs notes guidance cut on diagnostics headwinds - Investing.com Canada
Abbott profit forecast falls short, ramps up US investing amid tariff pressure - MSN
RSI Alert: Abbott Laboratories Now Oversold - Nasdaq
Abbott Earnings Beat Forecasts. Why the Stock Is Having Its Worst Day Since 2021. - Barron's
Abbott Narrows Its Outlook as COVID-19 Testing Demand Wanes. Its Stock Is Falling. - Yahoo Finance
Abbott Stock Falls in Pre-Market Despite Q2 Earnings and Sales Beat - Yahoo Finance
Abbott Labs stock falls as Goldman Sachs notes guidance cut on diagnostics headwinds By Investing.com - Investing.com South Africa
Abbott shares fall as it revises earnings due to tariffs, but still expects steady growth - Crain's Chicago Business
Abbott Laboratories shares slide as cautious guidance overshadows Q2 revenue beat - Proactive financial news
Earnings call transcript: Abbott Labs’ Q2 2025 results beat forecasts - Investing.com
GE Aerospace, Abbott Labs, Elevance: Trending Tickers - Yahoo Finance
Abbott Stock (ABT) Drops on Lower Full-Year Outlook; Sales Meet Estimates - Bloomberg
Abbott Stock Slips On Disappointing Q3 Earnings Forecast: Retail Chatter Rises Over 200% In 24 Hours - MSN
Abbott Laboratories falls after setting Q3 outlook below consensus - MSN
Abbott Labs Pares Outlook After Profit, Sales Gains - MSN
Abbott Drops on Lower Full-Year Outlook; Sales Meet Estimates - MSN
Abbott Laboratories reports results for the quarter ended June 30Earnings Summary - TradingView
Abbott (ABT) Reports Q2 Earnings: What Key Metrics Have to Say - Yahoo
Abbott Laboratories Sheds Nearly 5% On A Rare Guidance Miss - MSN
Abbott beats estimates on medical devices demand as forecast hits shares - Reuters
Abbott’s Q2 revenue surpasses expectations despite share decline - MSN
Abbott (ABT) Q2 2025 Earnings Call Transcript - The Globe and Mail
Abbott Laboratories Issues Weak Earnings Forecast, Joins MP Materials And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - 富途牛牛
Abbott Labs Stock Dives After Earnings Miss. Why Rising Sales Fail to Lift Shares. - MSN
Abbott (ABT) Q2 Earnings and Revenues Top Estimates - Yahoo
Why Abbott Laboratories' Q3 Earnings Disappointment Signals a Strategic Entry Point for Long-Term Investors - AInvest
Earnings Snapshot: Abbott Laboratories Q2 beats revenue estimates; narrows FY outlook range - Seeking Alpha
Abbott Labs Stock Falls as Earnings Miss. Rising Sales Fail to Lift Shares - Barron's
Abbott Laboratories Q2 2025 Earnings: EPS of $1.01 Beats Estimates, Revenue Reaches $11.142 Billion - GuruFocus
Abbott in charts: Medical Devices sees Y/Y double-digit growth momentum in Q2, up 13.4% - Seeking Alpha
Abbott Laboratories Boosts FY25 Adj. EPS OutlookUpdate - Nasdaq
Abbott beats profit estimates on medical devices demand, shares fall on forecast - Reuters
Abbott beats profit estimates on medical devices demand, shares fall on forecast By Reuters - Investing.com
Abbott Reports Second-Quarter 2025 Results - TradingView
Abbott Laboratories’s (NYSE:ABT) Q2 Sales Top Estimates - Yahoo Finance
Abbott’s Q2 revenue tops expectations but shares fall - Investing.com
Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo
Abbott Labs earnings beat by $0.01, revenue topped estimates - Investing.com Canada
Abbott beats quarterly profit estimates on medical devices demand - Reuters
Abbott Labs sales up by 7.4% to $11.14 billion - breakingthenews.net
Live: Abbott Labs (NYSE: ABT) Sinks 6% After Releasing Q2 Earnings - 24/7 Wall St.
Dow Jones down and Nasdaq flat as Abbott outlook disappoints, Pepsi impresses - Proactive Investors
Companies Reporting Earnings Before Tomorrow's Open: GE, Abbott, PepsiCo, and More - AInvest
1.41%
0.50%
자본화:
|
볼륨(24시간):